BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31346805)

  • 21.
    Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
    Quak E; Le Roux PY; Hofman MS; Robin P; Bourhis D; Callahan J; Binns D; Desmonts C; Salaun PY; Hicks RJ; Aide N
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2072-82. PubMed ID: 26219870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeatability of [
    Kolinger GD; Vállez García D; Kramer GM; Frings V; Smit EF; de Langen AJ; Dierckx RAJO; Hoekstra OS; Boellaard R
    EJNMMI Res; 2019 Feb; 9(1):14. PubMed ID: 30734113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUV variability in EARL-accredited conventional and digital PET.
    Koopman D; Jager PL; Slump CH; Knollema S; van Dalen JA
    EJNMMI Res; 2019 Dec; 9(1):106. PubMed ID: 31823097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Deauville Score for Response Evaluation in Hodgkin's Lymphoma.
    John JR; Oommen R; Hephzibah J; Mathew D; Korula A; Shanthly N; Eapen A
    Indian J Nucl Med; 2023; 38(1):16-22. PubMed ID: 37180196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.
    Lasnon C; Quak E; Le Roux PY; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
    EJNMMI Phys; 2017 Dec; 4(1):17. PubMed ID: 28560574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
    Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
    Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid Incidentaloma.
    Thuillier P; Bourhis D; Roudaut N; Crouzeix G; Alavi Z; Schick U; Robin P; Kerlan V; Salaun PY; Abgral R
    Front Med (Lausanne); 2019; 6():24. PubMed ID: 30809525
    [No Abstract]   [Full Text] [Related]  

  • 30. The Deauville 5-Point Scale Improves the Prognostic Value of Interim FDG PET/CT in Extranodal Natural Killer/T-Cell Lymphoma.
    Jiang C; Su M; Kosik RO; Zou L; Jiang M; Tian R
    Clin Nucl Med; 2015 Oct; 40(10):767-73. PubMed ID: 26164182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
    Bouard L; Bodet-Milin C; Bailly C; Guillaume T; Peterlin P; Garnier A; Bourgeois AL; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Bonnet A; Béné MC; Gouill SL; Moreau P; Kraeber-Bodéré F; Chevallier P
    Biol Blood Marrow Transplant; 2019 May; 25(5):906-911. PubMed ID: 30481598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of
    Isik EG; Kuyumcu S; Kebudi R; Sanli Y; Karakas Z; Cakir FB; Unal SN
    Ann Nucl Med; 2017 Nov; 31(9):660-668. PubMed ID: 28741053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital PET compliance to EARL accreditation specifications.
    Koopman D; Groot Koerkamp M; Jager PL; Arkies H; Knollema S; Slump CH; Sanches PG; van Dalen JA
    EJNMMI Phys; 2017 Dec; 4(1):9. PubMed ID: 28144857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of state of the art PET/CT systems performance harmonisation.
    Kaalep A; Sera T; Rijnsdorp S; Yaqub M; Talsma A; Lodge MA; Boellaard R
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1344-1361. PubMed ID: 29500480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours.
    Blautzik J; Grelich L; Schramm N; Henkel R; Bartenstein P; Pfluger T
    EJNMMI Res; 2019 Dec; 9(1):115. PubMed ID: 31872312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
    Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji J
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1837-48. PubMed ID: 27154522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs).
    Lasnon C; Enilorac B; Popotte H; Aide N
    EJNMMI Res; 2017 Dec; 7(1):30. PubMed ID: 28361349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Annunziata S; Cuccaro A; Calcagni ML; Hohaus S; Giordano A; Rufini V
    Ann Nucl Med; 2016 Oct; 30(8):588-92. PubMed ID: 27246952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.